---
title: "GNPX.US (GNPX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/GNPX.US/news.md"
symbol: "GNPX.US"
name: "GNPX.US"
parent: "https://longbridge.com/en/quote/GNPX.US.md"
datetime: "2026-05-20T22:59:20.752Z"
locales:
  - [en](https://longbridge.com/en/quote/GNPX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GNPX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GNPX.US/news.md)
---

# GNPX.US (GNPX.US) — Related News

### [Genprex Announces Positive Preclinical Data for Diabetes Gene Therapy](https://longbridge.com/en/news/286419469.md)
*2026-05-14T12:31:13.000Z*
> Genprex announced positive preclinical data for its diabetes gene therapy candidate GPX-002 at the 2026 American Society

### [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md)
*2026-05-14T12:13:01.000Z*
> Genprex announced preclinical data at ASGCT showing that its Pdx1/MafA gene therapy (PM) effectively reversed hyperglyce

### [Top 3 Health Care Stocks That Are Set To Fly In Q2](https://longbridge.com/en/news/285354489.md)
*2026-05-06T09:58:28.000Z*
> The health care sector has seen oversold stocks with RSI below 30, indicating potential buying opportunities. Key stocks

### [Genprex Expands Reqorsa Cancer Therapy Patent Protection in Israel](https://longbridge.com/en/news/284784032.md)
*2026-04-30T13:35:20.000Z*
> Genprex announced that the Israel Patent Office granted a patent for its Reqorsa Gene Therapy in combination with PD-1 a

### [Genprex Expands Lung Cancer Gene Therapy Research Collaboration](https://longbridge.com/en/news/283494492.md)
*2026-04-21T11:40:15.000Z*
> Genprex has announced a new Sponsored Research Agreement with The University of Texas MD Anderson Cancer Center to study

### [07:00 ETGenprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting](https://longbridge.com/en/news/279582194.md)
*2026-03-18T11:00:40.000Z*
> Genprex, Inc. announced that its research collaborators will present positive preclinical data on Reqorsa® Gene Therapy 

### [Congressman Who Bought Small-Cap Stocks In 2025 Is Back With New 2026 Pick: Here's What He's Buying](https://longbridge.com/en/news/276960817.md)
*2026-02-25T23:20:22.000Z*
> Congressman Tim Moore (R-N.C.) is making headlines again for his stock trades in 2026, focusing on small-cap companies. 

### [Hot pre-market trades in US stocks: Genprex up 15.86% pre-market; Keysight Tech up 14.70% pre-market](https://longbridge.com/en/news/276708334.md)
*2026-02-24T09:07:43.000Z*
> Genprex pre-market up 15.86%; Keysight Tech pre-market up 14.70%; Vir Biotechnology pre-market up 50.47%; Blue Hat pre-m